WASHINGTON (Reuters) - Iceland's Decode Genetics Inc, a pioneer in genetic research, has filed for bankruptcy protection, weighed down by debts after 13 years of failing to make a profit. Shares in ...

The combination of genomics, transcriptomics and proteomics sheds light on autoimmune thyroid disease, other autoimmune diseases and AML REYKJAVIK, Iceland, June 24, 2020 /PRNewswire/ -- Scientists at ...

Scientists at deCODE genetics, a subsidiary of AMGEN, have discovered rare sequence variants, predicted to cause a loss of function of ITSN1, that are associated with a high risk of Parkinson‘s ...

Scientists at deCODE genetics, a subsidiary of Amgen, have published a study in Nature Communications, comparing over 110 thousand patients with autoimmune thyroid disease (AITD) from Iceland, Finland ...

REYKJAVIK, Iceland, July 24, 2024 /PRNewswire/ -- A new study by scientists at deCODE Genetics, subsidiary of Amgen, shows that sequence variants drive the correlation between DNA methylation and gene ...

LONDON, Jan 21 (Reuters) - Iceland's Decode Genetics ehf returned as a private biotech company with new finance on Thursday after being acquired from its former parent by a consortium of investors.

Amgen, the world's largest biotech company by revenue, and deCODE, based in Reykjavik, Iceland, announced the all-cash deal Monday. DeCODE, founded in 1996, has discovered genetic risk factors for ...

Amgen has agreed to acquire deCode Genetics for $415 million. Based in Reykjavik, Iceland, deCode deciphers the links between genetics and human diseases largely by relying on Iceland’s exceptionally ...

REYKJAVIK, Iceland, June 24, 2020 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare system, University of Iceland and the ...